CareDx, Inc.

CDNASEC EDGAR

Services-Medical Laboratories(DE)CIK: 1217234

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$280.3M	$321.8M	$296.4M	$192.2M	$127.1M
Cost of Revenue	—	—	—	—	—
Gross Profit	—	—	—	—	—
Research and Development Expense	$82.4M	$90.4M	$76.5M	$48.9M	$30.7M
Operating Expenses	$483.7M	$399.0M	$326.1M	$214.7M	$151.6M
Operating Income (Loss)	-$203.4M	-$77.2M	-$29.7M	-$22.5M	-$24.5M
Nonoperating Income (Expense)	$13.2M	$997.0K	-$2.4M	$2.8M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$491.1M	$466.8M	$543.0M	$566.6M	$368.5M
Assets, Current	$351.8M	$313.7M	$387.8M	$433.4M	$273.1M
Cash and Cash Equivalents, at Carrying Value	$82.2M	$89.9M	$348.5M	$134.7M	$38.2M
Accounts Receivable, after Allowance for Credit Loss, Current	$64.6M	$51.1M	$66.3M	$59.8M	$34.6M
Inventory, Net	$19.5M	$19.5M	$19.2M	$17.2M	$10.0M
Liabilities	$112.6M	$205.5M	$112.1M	$100.7M	$90.8M
Liabilities, Current	$89.4M	$78.1M	$76.0M	$77.3M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	-$18.4M	-$25.2M	-$19.3M	$33.4M	-$2.8M
Net Cash Provided by (Used in) Investing Activities	$40.4M	-$228.5M	$47.7M	-$100.4M	-$22.6M
Net Cash Provided by (Used in) Financing Activities	-$29.6M	-$4.5M	$185.6M	$163.1M	-$132.0K
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—
Payments for Repurchase of Common Stock	$27.5M	$642.0K	$0.00	$0.00	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)